基于肝脂调控和肝毒性的大黄蒽醌机制研究进展

doi:10.19803/j.1672-8629.20240693

摘要/Abstract

摘要： 目的针对肝脂代谢异常疾病,细分大黄的效-毒物质基础,对大黄蒽醌的肝脂调控及其肝毒性机制进行综述,以期为治疗肝脂代谢异常疾病提供参考。方法通过检索建库至2024年9月5日使用中国知网、PubMed、Web of Science、Wiley、Google scholar等数据库,对各数据库所收录近10年内发表的有关大黄蒽醌调控肝脂及其导致肝毒性相关文献进行检索,并对其作用机制进行整理和总结。结果大黄蒽醌中的大黄素、大黄酸、大黄酚、芦荟大黄素、大黄素甲醚为大黄调控肝脂的物质基础,其作用机制主要与降低细胞外基质(Extracellular Matrix,ECM)相关I型胶原蛋白、α-平滑肌肌动蛋白(α-Smooth Muscle Actin,α-SMA)的表达、抑制肝纤维化,降低丙二醛(Malondialdehyde,MDA)、细胞内活性氧(Reactive Oxygen Species,ROS)表达水平、抑制肝脏氧化,降低白细胞介素-1α(Interleukin-1α,IL-١α)、肿瘤坏死因子-α(Tumor Necrosis Factor-α,TNF-α)等炎症介质的表达、减轻肝脏炎症等相关。同时,蒽醌类化合物的肝毒性作用机制主要与改变线粒体膜电位、破坏氧化磷酸化通路;增加ROS水平、引起细胞内氧化应激;引起胆红素代谢异常等相关。结论大黄蒽醌类化合物通过多成分、多靶点、多途径来调控肝脂代谢和诱发肝毒性。因此,应进一步探究大黄蒽醌类化合物在改善肝脂代谢相关疾病中的安全剂量范围,尽量减少潜在风险,以期优化其临床应用并获得更广泛的应用前景。

关键词: 大黄素, 大黄酸, 芦荟大黄素, 大黄酚, 大黄素甲醚, 肝脂调控, 肝毒性, 作用机制

Abstract: Objective To review the efficacy and toxicity material basis of rhubarb, especially the regulation of liver lipids by rhubarb anthraquinones, and the mechanisms of hepatotoxicity in order to facilitate the treatment of liver lipid metabolism disorders. Methods Literature published over the past 10 years (as of September 5, 2024) was retrieved from such databases as CNKI, PubMed, Web of Science, Wiley and Google scholar. Studies related to the regulation of liver lipids and hepatotoxicity induced by rhubarb anthraquinones were analyzed, and the mechanisms of action were summarized. Results The main anthraquinone compounds in rhubarb that regulated liver lipids included emodin, chrysophanol, aloe-emodin, and physcion. The mechanisms of action involved reducing the expressions of extracellular matrix (ECM)-related proteins such as type I collagen and a-smooth muscle actin (α-SMA) inhibiting liver fibrosis, reducing malondialdehyde (MDA) and reactive oxygen species (ROS) levels, and mitigating hepatic oxidative stress. Additionally, these anthraquinone compounds could reduce the expressions of inflammatory mediators, including interleukin-1α (IL-1α)and tumor necrosis factor-α(TNF-α) while alleviating liver inflammation. Meanwhile, the hepatotoxicity of anthraquinones was primarily linked to changes in mitochondrial membrane potential, disruption of oxidative phosphorylation, increased intracellular ROS, induction of oxidative stress, and abnormalities in bilirubin metabolism. Conclusion Rhubarb anthraquinones can regulate liver lipid metabolism and induce hepatotoxicity via multi-component, multi-target, and multi-pathway actions. More research is needed to determine the range of safe dosage, minimize risks, and optimize clinical applications for the treatment of liver lipid metabolism disorders.

Key words: Emodin, Rhein, Aloe Emodin, Chrysophanol, Emodin Methyl Ether, Liver Lipid Regulation, Liver Toxicity, Mechanism of Action

中图分类号:

R994.11
R977

刘颖, 宋绪钰, 孙蓉. 基于肝脂调控和肝毒性的大黄蒽醌机制研究进展[J]. 中国药物警戒, 2024, 21(12): 1432-1440.

LIU Ying, SONG Xuyu, SUN Rong. Research Progress in Mechanisms of Rhubarb Anthraquinone Based on Hepatic Lipid Regulation and Hepatotoxicity[J]. Chinese Journal of Pharmacovigilance, 2024, 21(12): 1432-1440.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://zgywjj.magtechjournal.com/CN/10.19803/j.1672-8629.20240693

https://zgywjj.magtechjournal.com/CN/Y2024/V21/I12/1432

参考文献

[1] XUE XP, TIAN Y, MA D, et al. Historical Textual Research and Modern Research on the Quality Evaluation of Three Kinds of Rhubarb Contained in“Chinese Pharmacopoeia”[J/OL]. Chinese Archives of Traditional Chinese Medicine(中华中医药学刊),(2024-03-28)[2024-06-25]. http://kns.cnki.net/kcms/detail/21.1546.R.20240326.1810.012.html.
[2] YANG TW, ZHOU JJ, LIAO Y, et al.Research Progress on Rhei Radix et Rhizoma in Prevention and Treatment of Liver Diseases[J]. Chinese Traditional and Herbal Drugs(中草药), 2023, 54(22): 7536-7544.
[3] JIANG H, CHEN J, ZENG C.Inhibitory Effect and Mechanism of Total Anthraquinones from Rhubarb on Hepatic Fibrosis[J]. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases(中西医结合肝病杂志), 2023, 33(11): 989-995.
[4] ZHANG R,CHAO X.Research Progress on the Effect and Mechanism of Emodin on Hepatocellular Carcinoma[J]. Journal of Liaoning University of Traditional Chinese Medicine(辽宁中医药大学学报), 2023, 25(11): 188-192.
[5] GUO HL,YAO JN, DONG L, et al.Effects of Physcion on NLRP3 Signaling Pathway and Gut Microbiota in Alcoholic Liver Fibrosis of Mice[J].Chinese Pharmacological Bulletin(中国药理学通报), 2024, 40(5): 999-1000.
[6] WANG HX, ZHANG SY, JIN Y, et al.Study on the Mechanism of Hepatotoxicity Induced by Rhubarb Based on Network Pharmacology and Experimental Verification[J]. Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology(世界科学技术-中医药现代化), 2024, 26(1): 167-178.
[7] QIN LS, ZHAO HP, ZHAO YL, et al.Protection and Bidirectional Effect of Rhubarb Anthraquinone and Tannins for Rats'Liver[J]. Chinese Journal of Integrated Traditional and Western Medicine(中国中西医结合杂志), 2014, 34(6): 698-703.
[8] JIN LX, JIN LJ, LUAN ZQ, et al.Research Progress on Chemical Constituents and Pharmacology of Rhubarb[J]. Information on Traditional Chinese Medicine(中医药信息), 2020, 37(1): 121-126.
[9] LI X, ZHUANG CY, DONG XR, et al.The Summary of Research and Application of Anthraquinone in Rhubarb[J]. Qinghai Prataculture(青海草业), 2018, 27(4): 49-53.
[10] QU YH, SUN Q, LI Y, et al.Advances in Biotransformation of Anthraquinone Compounds from Rhubarb[J]. Guangdong Chemical Industry(广东化工), 2018, 45(11): 124-125, 109.
[11] CUI Y, CHEN L J, HUANG T, et al.The Pharmacology, Toxicology and Therapeutic Potential of Anthraquinone Derivative Emodin[J]. Chin J Nat Med, 2020, 18(6): 425-435.
[12] HU Y, YANG L, LAI Y.Recent Findings Regarding the Synergistic Effects of Emodin and Its Analogs with other Bioactive Compounds: Insights into New Mechanisms[J]. Biomedicine & Pharmacotherapy, 2023, 162(1950-6007 Electronic): 114585.
[13] LIU WW, WANG YX, LIU SH, et al.Research Progress on Structural Modification of Emodin[J]. Journal of Xuzhou Institute of Technology(Natural Sciences Edition)(徐州工程学院学报自然科学版), 2019, 34(3): 27-33.
[14] SEMWAL RB, SEMWAL DK, COMBRINCK S, et al. Emodin-A Natural Anthraquinone Derivative with Diverse Pharmacological Activities[J]. Phytochemistry, 2021, 190(1873-3700 Electronic)): 112854.
[15] YU Y, WANG FL.Effects of Emodin on Liver Function in Rats with Acute Liver Failure and Its Mechanism[J]. Zhejiang Medical Journal(浙江医学), 2017, 39(7): 515-517.
[16] LI J, DING L, SONG B, et al.Emodin Improves Lipid and Glucose Metabolism in High Fat Diet-Induced Obese Mice through Regulating SREBP Pathway[J]. Eur J Pharmacol, 2016, 770(1879-0712 Electronic): 99-109.
[17] HUO GT, WANG YN, LV JJ, et al.Chronic Toxicity Study of Emodin Monomer in Kunming Mice by Ig administration[J]. Drug Evaluation Research(药物评价研究), 2021, 44(7): 1425-1433.
[18] HENAMAYEE S, BANIK K, SAILO BL, et al.Therapeutic Emergence of Rhein as a Potential Anticancer Drug: A Review of Its Molecular Targets and Anticancer Properties[J]. Molecules, 2020, 25(10):2278.
[19] FENG H, ZHU Y, FU Z, et al.Preparation, Characterization, and in Vivo Study of Rhein Solid Lipid Nanoparticles for Oral Delivery[J]. Chem Biol Drug Des, 2017, 90(5): 867-872.
[20] GAO X, FANG F.Structural Modification and Biological Research Progress of Rhein[J]. Chinese Journal of New Drugs(中国新药杂志), 2023, 32(1): 35-45.
[21] YANG D, HUANG WY, LI YQ, et al.Acute and Subchronic Toxicity Studies of Rhein in Immature and D-galactose-Induced Aged Mice and Its Potential Hepatotoxicity Mechanisms[J]. Drug Chem Toxicol, 2022, 45(3): 1119-1130.
[22] BOUNDA G A, ZHOU W, WANG D D, et al.Rhein Elicits in Vitro Cytotoxicity in Primary Human Liver HL-7702 Cells by Inducing Apoptosis through Mitochondria-Mediated Pathway[J]. Evid Based Complement Alternat Med, 2015, 2015(1741-427X Print): 329831.
[23] WANG WY, WANG R, LIU DX, et al.Interventions Effects of Rhein on Alcoholic Liver Damage Rats[J]. Chinese Journal of Coal Industry Medicine, 2017, 20(7): 838-841.
[24] WANG M, QIAO CY, WANG YY, et al.Research Progress of Chrysophanol Nanoparticles[J]. Acta Neuropharmacologica(神经药理学报), 2021, 11(6): 40-45.
[25] HU YZ, LI JM, LU ZZ, et al.The Effect of Chrysophanol on High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Neonatal Rats[J]. Immunological Journal(免疫学杂志), 2018, 34(10): 869-874.
[26] LIN L, YUAN F, LIU Y, et al.Hepatotoxicity and Mechanism Study of Chrysophanol-8-O-Glucoside In Vitro[J]. Biomedicine & pharmacotherapy, 2019, 120(1950-6007 Electronic): 109531.
[27] DONG X, ZENG Y, LIU Y, et al.Aloe-Emodin: A Review of Its Pharmacology, Toxicity, and Pharmacokinetics[J]. Phytother Res, 2020, 34(2): 270-281
[28] YU CP, SHIA CS, LIN HJ, et al.Analysis of the Pharmacokinetics and Metabolism of Aloe-Emodin Following Intravenous and Oral Administrations in Rats[J]. Biomed Chromatogr, 2016, 30(10): 1641-1647.
[29] LUOA H, JIA X, ZHANGA M, et al.Aloe-Emodin: Progress in Pharmacological Activity, Safety, and Pharmaceutical Formulation Applications[J]. Mini Rev Med Chem, 2024, 24(19): 1784-1798.
[30] SU Z L, HANG P Z, HU J, et al.Aloe-emodin Exerts Cholesterol-lowering Effects by Inhibiting Proprotein Convertase Subtilisin/Kexin Type 9 in Hyperlipidemic Rats[J]. Acta Pharmacol Sin, 2020, 41(8): 1085-1092.
[31] DONG X, FU J, YIN X, et al.Aloe-Emodin Induces Apoptosis in Human Liver HL-7702 Cells through Fas Death Pathway and the Mitochondrial Pathway by Generating Reactive Oxygen Species[J]. Phytother Res, 2017, 31(6): 927-936.
[32] XUNLI, LIU Y, CHU S, et al.Physcion and Physcion 8-O-β-glucopyranoside: A Review of Their Pharmacology, Toxicities and Pharmacokinetics[J]. Chem Biol Interact, 2019, 310: 108722.
[33] DONG PP, WANG SP, WANG YQ, et al.Analysis of Metabolites of Emodin Methyl Ether in Rats by UHPLC-Q-Exactive-Orbitrap HR-MS[J]. Chinese Traditional Patent Medicine(中成药), 2021, 43(12): 3524-3531.
[34] LI JF, WANG RJ, ZHANG YX, et al.Effect of Physcion on Alleviating Drug-Induced Liver Injury through HMGB1-NLRP3 Signaling Pathway[J]. Chinese Traditional and Herbal Drugs(中草药), 2022, 53(7): 2095-2102.
[35] WANG Q,YANG JB,WEN HR, et al.Safety of Emodin-Emodin Physcion Dianthrones[J]. Modern Chinese Medicine(中国现代中药), 2022, 24(8): 1425-1430.
[36] YANG ZH, CHEN HG, ZHAO WL, et al. Research Progress on Mechanism of Dahuang and Its Active Components in Treatment of Fatty Liver[J/OL]. Pharmacology and Clinics of Chinese Materia Medica(中药药理与临床), (2024-04-22)[2024-06-25]. https://doi.org/10.13412/j.cnki.zyyl.20240420.001.
[37] WU XY, DUAN WD, XIA PF, et al.Rapid Screening of Active Components from Rhei Radix et Rhizoma for Hypolipidemia by L02 Hepatic Steatosis Cell Membrane[J]. Chinese Traditional and Herbal Drugs(中草药), 2022, 53(3): 735-742.
[38] DONG HJ, LI H, TAO YJ, et al.Research Progress of Ancient Classic Prescription and Modern Chinese Medicine Compound Against Liver Fibrosis[J]. Chinese Journal of Integrated Traditional and Western Medicine(中国中西医结合杂志), 2023, 43(11): 1392-1400.
[39] WANG X, NIU C, ZHANG X, et al.Emodin Suppresses Activation of Hepatic Stellate Cells through p38 Mitogen-Activated Protein Kinase and Smad Signaling Pathways in Vitro[J]. Phytother Res, 2018, 32(12): 2436-2446.
[40] ZHAO XA, CHEN G, LIU Y, et al.Emodin Alleviates Liver Fibrosis of Mice by Reducing Infiltration of Gr1(hi) Monocytes[J]. Evid Based Complement Alternat Med, 2018, 2018(3): 5738101.
[41] GUO Y, LU FM, LIU DP.The Pathogenesis of Hepatic Fibrosis and the Effect of Rhein on Hepatic Fibrosis[J]. Journal of Medical Information(医学信息), 2020, 33(12): 27-32, 39.
[42] GUO MZ, LI XS,XU HR, et al.Rhein Inhibits Liver Fibrosis Induced by Carbon Tetrachloride in Rats[J]. Acta Pharmacol Sin, 2002, 23(8): 739-744.
[43] FANG JY, HUANG TH, CHEN WJ, et al.Rhubarb Hydroxyanthraquinones Act as Antiobesity Agents to Inhibit Adipogenesis and Enhance Lipolysis[J]. Biomedicine & pharmacotherapy, 2022, 146(146): 112497.
[44] LIU YZ, JIANG JY, LA MCD, et al.Research Progress on the Hypolipidemic Bioactive Components and Mechanism of Action of Rheum[J]. Journal of Food Safety & Quality(食品安全质量检测学报), 2023, 14(11): 272-282.
[45] FU X, XU AG, YAO MY, et al.Emodin Enhances Cholesterol Efflux by Activating Peroxisome Proliferator-Activated Receptor-Gamma in Oxidized Low Density Lipoprotein-loaded THP1 Macrophages[J]. Clin Exp Pharmacol Physiol, 2014, 41(9): 679-684.
[46] SU ZL, HANG PZ, HU J, et al.Aloe-emodin Exerts Cholesterol-lowering Effects by Inhibiting Proprotein Convertase Subtilisin/Kexin Type 9 in Hyperlipidemic Rats[J]. Acta Pharmacol Sin, 2020, 41(8): 1085-1092.
[47] WU C, BIAN Y, LU B,et al.Rhubarb Free Anthraquinones Improved Mice Nonalcoholic Fatty Liver Disease by Inhibiting NLRP3 Inflammasome[J]. J Transl Med, 2022, 20(1): 294.
[48] ZHUANG T, GU X, ZHOU N, et al.Hepatoprotection and Epatotoxicity of Chinese Herb Rhubarb (Dahuang): How to Properly Control the“General (Jiang Jun)”in Chinese Medical Herb[J]. Biomedicine & Pharmacotherapy, 2020, 127: 110224.
[49] XIONG SM, ZHANG JX, KANG W, et al.Emodin Induces Mitochondrial Apoptosis in Human Hepatoma HepG2 Cells[J]. Drug Evaluation Research(药物评价研究), 2018, 41(5): 773-779.
[50] PAN GT, LIU YH, ZHOU FY, et al.Protective Mechanism of Emodin on Lipopolysaccharide-Induced Acute Liver Injury by Reducing Oxidative Stress and Hepatocyte Apoptosis[J]. Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology(世界科学技术-中医药现代化), 2021, 23(7): 2294-2301.
[51] DOU ZH, XU B, SHI Z, et al.Study on the Liver and Kidney Toxicity and Effective Substances of Rhubarb Anthraquinone[J]. The Chinese Journal of Clinical Pharmacology(中国临床药理学杂志), 2018, 34(10): 1214-1217.
[52] LIU XY, SHI HH, WANG HW, et al.The Material Basis and Toxic Mechanism of Herb-Induced Liver Injury[J]. Journal of Clinical Hepatology(临床肝胆病杂志), 2024, 40(8): 1512-1518.
[53] HUANG QB, LIU MP.Mechanism of Hepatotoxicity of Rhei Radix et Rhizoma by Network Pharmacology and Molecular Docking[J]. Drugs & Clinic(现代药物与临床), 2023, 38(12): 2965-2970.
[54] WU J, MA Z, ZHANG Y, et al.Precise Subcellular Organelle-Targeted Analyses of the Hepatotoxicity of Rhubarb[J]. Acupuncture and Herbal Medicine, 2024, 4(2): 243-256.
[55] LIU DM, ZHOU CY, WU JS, et al.Emodin Induces Apoptosis in HepG2 Cells via Mitochondrial Pathway.[J]. Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2018, 24(3): 104-108.
[56] YANG XW, ZHANG YH, DUAN FP, et al.The Mechanism of Emodin Induced Liver Injury in Rats was Studied Based on Lable-Free Proteomics[J]. World Chinese Medicine(世界中医药), 2019, 14(2): 320-325.
[57] YOU L, DONG X, YIN X, et al.Rhein Induces Cell Death in HepaRG Cells through Cell Cycle Arrest and Apoptotic Pathway[J]. Int J Mol Sci, 2018, 19(4): 1060.
[58] HE LN, YANG AH, CUI TY, et al.Reactive Metabolite Activation by CYP2C19-Mediated Rhein Hepatotoxicity[J]. Xenobiotica, 2015, 45(4): 361-372.
[59] SUN H, LUO G, CHEN D, et al.A Comprehensive and System Review for the Pharmacological Mechanism of Action of Rhein, an Active Anthraquinone Ingredient[J]. Front Pharmacol, 2016, 7: 247.
[60] XU Y, MAO X, QIN B, et al. In Vitro and in Vivo Metabolic Activation of Rhein and Characterization of Glutathione Conjugates Derived from Rhein[J]. Chem Biol Interact, 2018, 283(1872-7786 Electronic): 1-9.
[61] LIU DM, YANG D, ZHOU CY, et al.Aloe-emodin Induces Hepatotoxicity by the Inhibition of Multidrug Resistance Protein 2[J]. Phytomedicine, 2020, 68: 153148.
[62] WANG Q, DAI Z, ZHANG YJ, et al.Hepatotoxicity of Emodin Based on UGT1A1 Enzyme-Mediated Bilirubin in Liver Microsomes[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2016, 41(23): 4424-4427.
[63] WANG Q, WANG YD, YANG JB, et al.Study on Hepatotoxicity of Emodin-8-O-β-D-Glucoside and Its Metabolites[J].China Journal of Chinese Materia Medica(中国新药杂志), 2020, 29(16): 1856-1862.
[64] ZHANG B, LV JT, ZHANG XM, et al.Traditional Chinese Medicine Property-Based Understanding of Toxicity, Efficacy and Pharmacovigilance[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2021, 18(5): 411-415.
[65] CHEN HY, LI L, XUE P, et al.Determination of Aurantio-Obtusin, Aloe-Emodin, Chrysophanol and Physcion in Rougan Jiangzhi Capsules by HPLC[J]. Drugs & Clinic(现代药物与临床), 2022, 37(5): 983-987.
[66] LIU XG, CHANG JH, WANG RX, et al. Extraction and Purification Techniques of Total Anthraquinones in Rhubarb, 2015, 35(15): 1366-1371.
[67] TANG YY.Review on Translation of Xu Dachun's Phangma Lun (Treatise on Pharmacy) in the Qing Dynasty[J]. Modern Chinese Medicine(中国现代中药), 2017, 19(9): 1315-1317.
[68] WANG M, HAN T, LI CS, et al.Chemical Components and Toxicity of Radix et Rhizoma Rhei before and after Processing[J]. World Chinese Medicine(世界中医药), 2022, 17(22): 3131-3138.